Technologies Available for Licensing

For Licensing Opportunities, please contact the ORTA at


In this application is described the production of recombinant, chimeric, humanized antibodies specific for both BoNt/A and BoNT/B. The humanized antibodies were converted from a mouse anti-BoNT/A/B Fab fragment into a whole human IgG1 antibody. The antibodies are useful in assays for detecting human exposure to BoNT/A and BoNT/B.

Docket:RIID 05-26

Publication/Issued No.:7,563,875

Publication/Issue Date:2009-07-21

Categories: Antibody Technologies

More Detail:Visit USPTO.GOVExternal link


Inventor(s):PALYS, T.; SCHOEPP, R.; SCHMID K.

For Licensing Opportunities, please contact the ORTA at

Last Modified Date: 25 Jul 2023

This Web site provides an introduction to the Office of Research and Technology Applications (ORTA) and contains official Government information.

Its use is intended for members of the general public, news media and Military Health System beneficiaries.

Please address questions or concerns about this Web site to the USAMRDC Public Affairs Office at: or by telephone at (301)619-2736.